Name: Algorae Pharmaceuticals (1AI) Short Position History
Creator: Shorted
License: https://creativecommons.org/licenses/by/4.0/

1AI

Algorae Pharmaceuticals

Pharmaceuticals, Biotechnology & Life Sciences

Algorae Pharmaceuticals Limited focuses on the development and commercialization of innovative pharmaceuticals and biotechnology products. The company leverages cutting-edge research to address unmet medical needs across various therapeutic areas. Its market position is bolstered by a robust pipeline of drugs that target specific industry demands, making it a key player in pharmaceutical innovation.

Short position

short percentage0.00%

reported shorts16.8K

shares on issue2.028B

Algorae Pharmaceuticals (ASX:1AI) has 0.00% of its shares on issue reported as short positions as of 5 Oct 2026, or about 16,823 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. 1AI is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.

Price & short interest

Toggle series, zoom, and compare · ASIC daily, T+4

Short interest

History & FAQ →

Weekly context: The 10 most shorted ASX stocks — Week 41, 2026.

Strategy fit

How each stock picker strategy reads 1AI today

Zanger BreakoutNot a candidate
CAN SLIMNot a candidate
Minervini Trend TemplateNot a candidate
Crowded-Short BreakoutNot a candidate
Quality compoundersNot a candidate

Prices to 9 Oct 2026 · Mechanical readings of published rules, not recommendations · Not financial adviceFull strategy readings →

1AI fundamentals

In the year to 30 Jun 2026, Algorae Pharmaceuticals (ASX:1AI) recorded revenue of A$77.7K and a net loss after tax of A$2.7M. A year earlier it recorded revenue of A$141.1K and a net loss after tax of A$803.0K. Year-on-year growth: revenue −44.9% (FY). Net margin −3,490.0% (FY). Figures are in AUD, the company's reporting currency; source: ASX (Markit), as at 29 Sep 2026.

Full statements, ratios and filings are on the Financials tab. Not financial advice.

Full financials →